Antifungal
Top View
- Mammalian Target of Rapamycin Inhibitors Rapamycin and RAD001 (Everolimus) Induce Anti-Proliferative Effects in GH-Secreting Pituitary Tumor Cells in Vitro
- Annual Report of Antibiotic and Antimycotic Consumption 2019
- Antifungal Drug Itraconazole Targets VDAC1 to Modulate the AMPK/Mtor Signaling Axis in Endothelial Cells
- Potential Antifungal Targets Against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade—A Review
- Guidelines for Environmental Infection Control in Health-Care Facilities
- Psychoactive Medications
- An Updated Review of Interactions of Statins with Antibacterial and Antifungal Agents
- ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
- Ketoconazole Binds to Glucocorticoid Receptors and Exhibits Glucocorticoid Antagonist Activity in Cultured Cells
- Sb249-Appendix
- Increased Susceptibility to Infection Is a Complication of Mtor Inhibitor Use in Cancer Therapy Adrian M
- Antifungal Activity of Statins and Their Interaction with Amphotericin B Against Clinically Important Zygomycetes
- Antifungal Drug Repurposing
- A Machine Learning Approach for Investigating Delirium As a Multifactorial Syndrome
- Ketoconazole) Tablets
- In Vitro Activity of Calcium Channel Blockers in Combination with Conventional Antifungal Agents Against Clinically Important Filamentous Fungi
- IRRADIATION EFFECT on ANTIFUNGAL POTENTIAL Myristica Fragrans (NUTMEG) ESSENTIAL OIL, a PRELIMINARY STUDY
- Clinically Relevant Interactions Between Atypical Antipsychotics and Anti-Infective Agents